CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The NOA device provides a non-invasive method for monitoring asthma by measuring exhaled nitric oxide. It aims to improve early diagnosis and management of asthma in clinical settings.
In Europe, about 30 million children and adults under 45 years old have asthma.
There is no cure for asthma, it is a chronic disease.
Asthma can have a very negative impact on the quality of life of those people who suffer from it.
However, it can be diagnosed and effectively controlled at an early stage.
The total cost of the disease for the European population aged between 15 and 64 was EUR 19.3 billion per year.We have developed the NOA device, that monitors asthma in a simple, painless, non-…
EVERSENS SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
